Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
2.900
+0.050 (1.75%)
Jul 2, 2026, 4:00 PM EDT - Market closed
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $1.05 billion as of July 2, 2026. Its market cap has decreased by -21.54% in one year.
Market Cap
1.05B
Enterprise Value
979.56M
1-Year Change
-21.54%
Ranking
Category
Stock Price
$2.90
Market Cap Chart
Since the IPO on November 4, 2021, Evotec SE's market cap has decreased from $9.19B to $1.05B, a decrease of -88.63%. That is a compound annual growth rate of -37.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 1.05B | -8.07% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | -8.26% |
| Nov 4, 2021 | 9.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Perrigo Company | 1.52B |
| Xeris Biopharma Holdings | 1.43B |
| Phibro Animal Health | 1.35B |
| Alvotech | 1.22B |
| Collegium Pharmaceutical | 1.20B |
| BioAge Labs | 1.12B |
| Cronos Group | 1.05B |
| Eton Pharmaceuticals | 1.03B |